Joseph G Wettstein, PhD

Noema Pharma AG
Basel, Switzerland

Disclosure information not submitted.

Presentation(s):

• SUN-151 - Rationale for Cendifensine, A Broad-Spectrum Monoamine Modulator, to Treat Vasomotor and Other Symptoms in Menopause

  Sunday, June 14, 2026
  9:00 AM - 4:00 PM CT